Issue 7/2024
Content (20 Articles)
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data
Justin C. Moser, Shailender Bhatia, Asim Amin, Anna C. Pavlick, Keith A. Betts, Ella Xiaoyan Du, Tayla Poretta, Karishma Shelley, Swetha Srinivasan, Leon Alan Sakkal, Jennell Palaia, Maurice Lobo, Melanie Pe Benito, Joshua A. Linton, Yan Chen, Churong Xu, Lei Yin, Manasvi Sundar, Jeffrey Weber
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Yansong Liu, Mingcui Li, Zhengbo Fang, Shan Gao, Weilun Cheng, Yunqiang Duan, Xuelian Wang, Jianyuan Feng, Tianshui Yu, Jiarui Zhang, Ting Wang, Anbang Hu, Hanyu Zhang, Zhiyuan Rong, Suborna S. Shakila, Yuhang Shang, Fanjing Kong, Jiangwei Liu, Yanling Li, Fei Ma
Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy
Barbara Bailly-Caillé, Romain Levard, Diane Kottler, Anne Dompmartin, Jean-Matthieu L’Orphelin
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer
Panpan Zhang, Zhendong Chen, Si Shi, Zhiping Li, Feng Ye, Lijie Song, Yanqiao Zhang, Fei Yin, Xing Zhang, Jianming Xu, Ying Cheng, Weiguo Su, Michael Shi, Songhua Fan, Panfeng Tan, Chen Zhong, Ming Lu, Lin Shen
Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study
Song Guan, Jifeng Sun, Yuan Wang, Sibei Han, Chen Chen, Dongsheng Yue, Yubei Huang, Kai Ren, Jun Wang, Jun Wang, Lujun Zhao
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy
Jia-Lin Feng, Bo Liang, Wen-Jie Zheng, Le Xu, Qin-Yi Zhou, Jun Chen
Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma
Xin Wu, Tao Mi, Liming Jin, Chunnian Ren, Jinkui Wang, Zhaoxia Zhang, Jiayan Liu, Zhaoyin Wang, Peng Guo, Dawei He
Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score
Chaoting Zhang, Shance Li, Luyan Shen, Xia Teng, Yefei Xiao, Wenjun Yang, Zheming Lu
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study
Shengxiang Ren, Anwen Xiong, Jia Yu, Xicheng Wang, Baohui Han, Yueyin Pan, Jun Zhao, Yufeng Cheng, Sheng Hu, Tianshu Liu, Yalun Li, Ying Cheng, Jifeng Feng, Shanyong Yi, Shanzhi Gu, Shegan Gao, Yongzhong Luo, Ying Liu, Caigang Liu, Huijie Duan, Shuni Wang, Xinfeng Yang, Jia Fan, Caicun Zhou
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis
Ya-Nan Jin, Meng-Yun Qiang, Ying Wang, Yu-Jing Lin, Ren-Wei Jiang, Wan-Wei Cao, Wang-Jian Zhang, Si-Yang Wang, Hong-Yu Zhang, Ji-Jin Yao
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study
Tatsuki Ikoma, Toshihiko Matsumoto, Shogen Boku, Yusuke Motoki, Hidefumi Kinoshita, Hisashi Kosaka, Masaki Kaibori, Kentaro Inoue, Mitsugu Sekimoto, Takuo Fujisawa, Hiroshi Iwai, Makoto Naganuma, Hideaki Tanizaki, Yoji Hisamatsu, Hidetaka Okada, Takayasu Kurata
Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment
Peng Zhang, Yi Wan, Jinrong Ma, Jin Gong, Ziwei Zhong, Yuxin Cui, Hongli Zhang, Yanyan Da, Junpeng Ma, Chenxi Li, Lijuan Liu, Tian Gong, Youwen Tan, Chengsheng Zhang
Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype
Hongxu Liu, Maojin Yao, Jiaoyan Ren
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer
Fenbao Lian, Haitao Yang, Rujun Hong, Hang Xu, Tingting Yu, Gang Sun, Guanying Zheng, Baosong Xie
circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 manner
Zhiling Zhang, Wenjie Huo, Jie Li
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis
Ji-Bin Li, Ming-Yu Lai, Zhuo-Chen Lin, Wen-Long Guan, Yu-Ting Sun, Jing Yang, Wen-Xuan Wang, Zhi-Rong Yang, Miao-Zhen Qiu
Effect of radiochemotherapy on peripheral immune response in glioblastoma
Léa Hampe, Susy Daumoine, Emeric Limagne, Nicolas Roussot, François Borsotti, Julie Vincent, Sylvia Ilie, Caroline Truntzer, François Ghiringhelli, Marion Thibaudin
The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study
Xiaoyan Yin, Xinchao Liu, Fei Ren, Xiangjiao Meng
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, Yoko Adachi, Naoyuki Anzai, Masaaki Hotta, Kentaro Fukushima, Hideo Yagi, Satoshi Yoshihara, Yasuhiro Tanaka, Teruhito Takakuwa, Hirokazu Tanaka, Hirohiko Shibayama, Nobuhiko Uoshima, Naoki Hosen, Tomoki Ito, Chihiro Shimazaki, Itaru Matsumura, Junya Kuroda, Akifumi Takaori-Kondo, Masayuki Hino